(Q35648314)

9 August 2017

In vitro evaluation of A-56619 and A-56620, two new quinolones (English)

1 reference

9 August 2017

0 references

3

Jones RN

1 reference

9 August 2017

2

Thornsberry C

1 reference

9 August 2017

1

Barry AL

1 reference

PubMed ID

2942099

9 August 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

Antimicrobial Agents and Chemotherapy

9 August 2017

1 reference

9 August 2017

29

1 reference

9 August 2017

1

1 reference

9 August 2017

40-43

1 reference

In vitro and in vivo activity of DL-8280, a new oxazine derivative

9 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180360

In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180360

Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180360

In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180360

27 July 2018

Identifiers

DOI

10.1128/AAC.29.1.40

1 reference

9 August 2017

1 reference

9 August 2017

1 reference

PubMed ID

2942099